A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorZhe Meng
About this trial
The goal of this clinical trial is to exploring the role of tubeless after adrenalectomy surgery. The main questions it aims to answer are:
1. The safety of tubeless laparoscopic adrenalectomy； 2. The role of tubeless therapy in rapid recovery after adrenalectomy surgery Participants will be randomly divided into two groups: the non drainage group and the drainage group after laparoscopic adrenal surgery, and their pain, first time out of bed, and intestinal recovery time will be observed.
Eligibility criteria
Qualifiers
According to the 2022 edition of the Chinese Guidelines for Diagnosis and Treatment of Urological Diseases, patients who meet the surgical indications
The patient has signed an informed consent form before joining the clinical trial, and the age at the time of signing the informed consent form is 18-70 years old.
Disqualifiers
Patients with complications that seriously affect treatment or quality of life
The patient has any physical condition that the researcher believes will affect the clinical status
Patients who have placed vascular stents such as heart and cerebrovascular stents within the past year
Pregnant or lactating patients
Trial design
Treatments tested in this trial
- Tubeless laparoscopic adrenalectomy
- Drainage tube
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Zhe Meng
Lead sponsor
Zhongnan Hospital
Sponsor institution
Source ClinicalTrials.gov